ABSTRACT
Immunoglobulin G4-related disease (IgG4-RD) is a systemic condition accompanied by tumefactive lesions, dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, storiform fibrosis in various organs, and, frequently, elevated serum IgG4 levels. Chronic sclerosing sialadenitis (also termed Küttner's tumor) is thought to be a lesion of IgG4-RD; thus, IgG4-related sialadenitis may be the initial symptom of IgG4-RD. We herein report a 64-year-old Japanese female with IgG4-related chronic sclerosing sialadenitis of the right submandibular gland and retroperitoneal fibrosis, who subsequently developed tubulointerstitial nephritis and pancreatitis. She was referred to our Department for treatment of swelling of the right submandibular gland; preoperative imaging studies suggested a malignant tumor. We extirpated the submandibular glands bilaterally and diagnosed IgG4-related chronic sclerosing sialadenitis pathologically. Subsequently, the patient's serum IgG4 concentration increased, and lesions in the retroperitoneum, kidney, and pancreas were confirmed by imaging. Although the radiological characteristics of these lesions mimicked malignancy, steroid treatment was commenced based on the pathology of the submandibular gland and elevated serum IgG4 level. This caused the lesions to disappear, indicating that the patient had experienced IgG4-related retroperitoneal fibrosis, tubulointerstitial nephritis, and pancreatitis. No relapse was detected for 4 years 8 months after surgery. A pathological diagnosis is crucial to exclude the possibility of malignancy and to make treatment decisions when lesions are evident in other organs. In addition, periodic evaluation of the serum IgG4 concentration and imaging of the whole body are warranted in long-term follow-up.
Subject(s)
Autoimmune Diseases/pathology , Immunoglobulin G/blood , Prednisolone/therapeutic use , Sialadenitis/pathology , Submandibular Gland/pathology , Autoimmune Diseases/drug therapy , Female , Histological Techniques , Humans , Japan , Magnetic Resonance Imaging , Middle Aged , Pancreatitis/pathology , Prednisolone/pharmacology , Retroperitoneal Fibrosis/pathology , Submandibular Gland/surgeryABSTRACT
Bone metabolism is maintained via balanced repetition of bone resorption by osteoclasts and bone formation by osteoblasts. Osteoblastic cells are capable of conducting self-renewal and differentiation that are basically associated with cell-cycle transition to enable cell specification and bone formation. Osteoblasts are also migrating to fill the resorption cavity curved by osteoclasts during bone remodeling to maintain homeostasis of bone mass whose imbalance leads to osteoporosis. However, technical difficulties have hampered the research on the dynamic relationship between cell cycle and migration in osteoblasts. In this report, we overcome these problems by introducing fluorescent ubiquitination-based cell cycle indicator (FUCCI) reporter system in calvarial osteoblastic cells and reveal that the cells in G1 as well as S/G2 /M phase are migrating. Furthermore, the osteoblastic cells in S/G2 /M phase migrate faster than those in G1 phase. Interestingly, parathyroid hormone (PTH) as an anabolic agent enhances migration velocity of the cells. Mechanical stress, another anabolic signal, also enhances migration velocity. In contrast, in the presence of both PTH and mechanical stress, the migration velocity returns to the base line levels revealing the interaction between the two anabolic stimuli in the regulation of cell migration. Importantly, PTH and mechanical stress also interact when they regulate the transition of cell cycle. These data demonstrate that osteoblastic migration is linked to cell cycle and it is under the control of mechanical and chemical stimuli that coordinate to regulate bone mass.
Subject(s)
Biosensing Techniques , Bone Remodeling , Cell Cycle , Cell Movement , Cell Tracking/methods , Mechanotransduction, Cellular , Osteoblasts/metabolism , Parathyroid Hormone/metabolism , Animals , Cells, Cultured , Genes, Reporter , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Mice , Mice, Transgenic , Stress, Mechanical , Time FactorsABSTRACT
The molecular mechanisms underlying bone destruction by invading oral cancer are not well understood. Using IHC, we demonstrated that receptor activator of nuclear factor-κB ligand (RANKL)-positive fibroblasts and cancer cells were located at sites of bone invasion in human oral cancers. HSC3 and HO-1-N-1, human oral cancer cell lines, expressed RANKL and stimulated Rankl expression in the UAMS-32 murine osteoblastic cell line. We discriminated the roles of RANKL synthesized by stromal cells and cancer cells in cancer-associated bone resorption by using species-specific RANKL antibodies against murine RANKL and human RANKL, respectively. Osteoclastogenesis induced by the conditioned medium of HSC3 and HO-1-N-1 cells in a co-culture of murine bone marrow cells and UAMS-32 cells was inhibited by the addition of antibodies against either mouse or human RANKL. HSC3-induced bone destruction was greatly inhibited by the administration of anti-mouse RANKL antibody in a xenograft model. HO-1-N-1-induced bone destruction was inhibited by the administration of either anti-mouse or anti-human RANKL antibody. Bone destruction induced by the transplantation of human RANKL-overexpressing cells (HSC3-R2) was greatly inhibited by the injection of anti-human RANKL antibody. The present study revealed that RANKL produced by both stromal and cancer cells is involved in oral cancer-induced osteoclastic bone resorption. These results provide important information for understanding the cellular and molecular basis of cancer-associated bone destruction and the mechanism of action underlying RANKL antibody (denosumab) therapy.
Subject(s)
Bone Resorption/etiology , Bone Resorption/pathology , Mouth Neoplasms/complications , Mouth Neoplasms/pathology , Osteoclasts/pathology , RANK Ligand/biosynthesis , Animals , Antibodies/pharmacology , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Bone Resorption/metabolism , Cell Line, Tumor , Coculture Techniques , Gene Expression Regulation, Neoplastic/drug effects , Humans , Mice , Mouth Neoplasms/genetics , Neoplasm Invasiveness , Osteoclasts/drug effects , Osteoclasts/metabolism , Osteogenesis/drug effects , Osteogenesis/genetics , Osteoprotegerin/metabolism , RANK Ligand/genetics , Stromal Cells/metabolism , Stromal Cells/pathology , Xenograft Model Antitumor AssaysABSTRACT
The primary treatment modality of oral cancer is generally determined according to the stage of the disease, with surgical treatment remaining the mainstay of multimodal treatment. When selecting the treatment, many factors are taken into consideration, and the treatment should be tailored individually to the patient's needs and consider the quality of life as well as the survival of the patient. Early-stage disease is primarily managed with surgery or brachytherapy without functional morbidity, whereas for advanced-stage disease multidisciplinary treatment is recommended, not only for enhanced survival but also for improved quality of life. After resection of large primary tumors, reconstructive surgery is required. Free tissue transfer currently represents one of the most popular and reliable techniques for oral reconstruction. For cN0 neck, elective neck dissection is recommended when the risk of occult metastases is >20 %, when the neck is entered either for resection of the primary tumor or for reconstruction, or when the patient is unlikely to return for a close follow-up. Sentinel node biopsy is performed investigationally. Modified radical neck dissection is the gold standard for cN+ neck. For patients with multiple node metastases or extracapsular spread, postoperative radiotherapy or chemoradiotherapy is recommended, with the lymph nodes situated outside the confines of the radical neck dissection, such as the lingual and retropharyngeal nodes, receiving considerable attention. Targeted therapy for oral cancer is still a relatively new concept, and more studies are needed to confirm the clinical effectiveness of these drugs.
Subject(s)
Carcinoma, Squamous Cell/surgery , Mouth Neoplasms/pathology , Mouth Neoplasms/surgery , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Combined Modality Therapy , Humans , Lymph Nodes/pathology , Mouth Mucosa/pathology , Mouth Mucosa/surgery , Mouth Neoplasms/therapy , Neck Dissection/methods , Tongue Neoplasms/pathology , Tongue Neoplasms/surgeryABSTRACT
PURPOSE: The aim of the present study was to evaluate the feasibility of a gelatin hydrogel system to enhance recombinant human fibroblast growth factor-2 (rhFGF-2)-induced osteogenic effects during rat mandibular distraction. MATERIALS AND METHODS: Mandibular distraction was performed in 28 male Wistar rats. Then, the rats were divided into 5 groups in which the designated gel mix was inserted into the distracted area: group 1, rhFGF-2 alone (n = 5); group 2, collagen alone (n = 6); group 3, collagen incorporating rhFGF-2 (n = 6); group 4, gelatin hydrogel alone (n = 5); and group 5, gelatin hydrogel incorporating rhFGF-2 (n = 6). The mandibles were excised 29 days after surgery and the newly formed bone was analyzed radiologically and histologically. The experimental groups were compared using the Fisher post hoc test (95% statistical significance threshold; P < .05). RESULTS: Peripheral quantitative computed tomographic analysis, von Kossa staining, and calcein staining showed that using gelatin hydrogel with rhFGF-2 (group 5) significantly increased cortical bone mineral density, the domain area of hard tissue, the domain area of cortical bone area, total bone mineral content, cortical bone mineral content, the von Kossa-stained area, and the calcein-stained area compared with the collagen carrier (group 3). Group 5 also had a significantly larger number of cells positive for tartrate-resistant acid phosphatase compared with group 3 and radiopaque areas were observed more frequently. CONCLUSIONS: The present findings suggest that gelatin hydrogel is a feasible delivery system for rhFGF-2, and when used together perform better in regard to hard tissue healing and treatment time after surgery.
Subject(s)
Fibroblast Growth Factor 2/therapeutic use , Gelatin/chemistry , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Mandible/surgery , Osteogenesis, Distraction/methods , Recombinant Proteins/therapeutic use , Acid Phosphatase/analysis , Anatomy, Cross-Sectional , Animals , Biomarkers/analysis , Bone Density/drug effects , Collagen/chemistry , Coloring Agents , Drug Carriers , Feasibility Studies , Fluoresceins , Fluorescent Dyes , Humans , Isoenzymes/analysis , Male , Mandible/drug effects , Osteogenesis/drug effects , Rats, Wistar , Tartrate-Resistant Acid Phosphatase , Tomography, X-Ray Computed/methods , X-Ray Microtomography/methodsABSTRACT
BACKGROUND: Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder and is characterized by tumorigenesis and physical deformity. Keratocystic odontogenic tumors (KCOTs) of the jaws are a common manifestation of this syndrome. This study involved a pooled analysis of Japanese individuals with NBCCS and was performed with the aim of analyzing the clinical features of NBCCS and the patterns of occurrence and recurrence of KCOTs in Japanese individuals. METHODS: This study included 25 patients. The relative frequencies of the major symptoms in these patients were compared with those reported in the literature. We also investigated 11 patients with KCOTs (40 lesions) initially treated at Tokyo Medical and Dental University. RESULTS: KCOTs (100%) and palmar and/or plantar pits (n = 19; 76.0%) were the most frequently observed manifestations. Eleven patients (44.0%) had a radiologically confirmed rib anomaly. Nineteen patients (76.0%) had a family history of the syndrome within first-degree relatives. Japanese patients had a relatively low frequency of basal cell carcinoma (n = 7; 28.0%) and falx calcification (n = 7; 28.0%) compared with that reported in other populations. Twelve of the total 40 KCOTs (30.0%) that were followed up for 6 months or more recurred. All recurrent cases had undergone conservative treatment, whereas no recurrences occurred in cases that had undergone radical treatment. CONCLUSIONS: Recurrence of KCOTs associated with NBCCS is frequently encountered, and further investigations are required to confirm the optimal treatment that will ensure a complete cure improving the patient's quality of life.
Subject(s)
Basal Cell Nevus Syndrome/pathology , Odontogenic Tumors/pathology , Adolescent , Adult , Aged , Basal Cell Nevus Syndrome/genetics , Carcinoma, Basal Cell/pathology , Child , Dura Mater/pathology , Female , Follow-Up Studies , Foot Deformities/pathology , Hand Deformities/pathology , Humans , Japan , Male , Mandibular Neoplasms/pathology , Mandibular Neoplasms/surgery , Maxillary Neoplasms/pathology , Maxillary Neoplasms/surgery , Middle Aged , Neoplasm Recurrence, Local/pathology , Odontogenic Tumors/genetics , Odontogenic Tumors/surgery , Ossification, Heterotopic/pathology , Quality of Life , Ribs/abnormalities , Young AdultABSTRACT
Notch is a transmembrane receptor functioning in the determination of cell fate. Abnormal Notch signaling promotes tumor development, showing either oncogenic or tumor suppressive activity. The uncertainty about the exact role of Notch signaling, partially, stems from inconsistencies in descriptions of Notch expression in human cancers. Here, we clarified basal-cell dominant expression of NOTCH1 in squamous epithelium. NOTCH1 was downregulated in squamous neoplasms of oral mucosa, esophagus and uterine cervix, compared with the normal basal cells, although the expression tended to be retained in cervical lesions. NOTCH1 downregulation was observed even in precancers, and there was little difference between cancers and high-grade precancerous lesions, suggesting its minor contribution to cancer-specific events such as invasion. In culture experiments, reduction of NOTCH1 expression resulted in downregulation of keratin 13 and keratin 15, and upregulation of keratin 17, and NOTCH1 knockdown cells formed a dysplastic stratified epithelium mimicking a precancerous lesion. The NOTCH1 downregulation and the concomitant alterations of those keratin expressions were confirmed in the squamous neoplasms both by immunohistochemical and cDNA microarray analyses. Our data indicate that reduction of NOTCH1 expression directs the basal cells to cease terminal differentiation and to form an immature epithelium, thereby playing a major role in the histopathogenesis of epithelial dysplasia. Furthermore, downregulation of NOTCH1 expression seems to be an inherent mechanism for switching the epithelium from a normal and mature state to an activated and immature state, suggesting its essential role in maintaining the epithelial integrity.
Subject(s)
Carcinoma, Squamous Cell/pathology , Esophageal Neoplasms/pathology , Keratinocytes/pathology , Keratins, Type I/metabolism , Mouth Neoplasms/pathology , Precancerous Conditions/pathology , Receptor, Notch1/metabolism , Uterine Cervical Neoplasms/pathology , Animals , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Cell Differentiation , Cell Line, Tumor , Down-Regulation , Esophageal Neoplasms/genetics , Esophageal Neoplasms/metabolism , Female , Humans , Immunohistochemistry , Keratin-13/genetics , Keratin-13/metabolism , Keratin-15/genetics , Keratin-15/metabolism , Keratin-17/genetics , Keratin-17/metabolism , Keratinocytes/cytology , Keratinocytes/metabolism , Keratins, Type I/genetics , Male , Mice , Mouth Neoplasms/genetics , Mouth Neoplasms/metabolism , Oligonucleotide Array Sequence Analysis , Precancerous Conditions/genetics , Precancerous Conditions/metabolism , Receptor, Notch1/genetics , Up-Regulation , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/metabolismABSTRACT
Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by developmental defects and tumorigenesis. The gene responsible for NBCCS is PTCH1. The PTCH1 gene has five alternatively used first exons resulting in the translation of three isoforms of the PTCH1 protein; that is, PTCHL, PTCHM and PTCHS. However, the biological significance of each isoform is unclear. Here we show an individual with NBCCS carrying a nonsense mutation in PTCH1 exon2, c.387G>A (p.W129X). As the mutation lay upstream of the ATG codon used for PTCHS translation, the mutant allele still expressed RNA isoforms that encode PTCHS. These results clearly demonstrate that a selective haploinsufficiency of longer isoforms of the PTCH1 protein, PTCHL and PTCHM, but not PTCHS is sufficient to cause NBCCS. Although mice selectively deficient in PTCHS isoforms are currently unavailable, this study sheds light on the complex in vivo roles of PTCH1 isoforms.
Subject(s)
Basal Cell Nevus Syndrome/genetics , Haploinsufficiency , Receptors, Cell Surface/genetics , Basal Cell Nevus Syndrome/metabolism , Basal Cell Nevus Syndrome/pathology , Child , Codon, Nonsense/genetics , Exons , HEK293 Cells , Humans , Male , Patched Receptors , Patched-1 Receptor , Protein Biosynthesis , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/analysis , RNA, Messenger/genetics , Receptors, Cell Surface/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , TransfectionABSTRACT
BACKGROUND: Oral leukoplakia can be treated using a variety of treatment procedures; however, the lesions recur in many cases irrespective of the treatment procedure used. The rate of recurrence was from 7.7% to 38.1%. This study aims to identify the important factors that can lower the risk of recurrence of oral leukoplakia treated by curative surgical resection. METHODS: The clinical records of 52 patients with oral leukoplakia (53 lesions) who underwent curative surgical resection between 2004 and 2009 were retrospectively analyzed for the rate of recurrence, clinical outcome, epithelial dysplasia, lesion location, and resection margins. RESULTS: The recurrence rate following curative surgical resection was 15.1%, with the most common site being the gingiva. Malignant transformation occurred in a single patient (1.9%). Minimal resection margins (<3 mm) were observed in many patients with recurrent disease, and recurrence was more likely in cases with positive margins (epithelial abnormalities at the resection margins) than in those with negative margins. There was no significant association between recurrence and the degree of epithelial dysplasia. CONCLUSIONS: Our data suggest that surgical resection of oral leukoplakia is curative only if all areas of epithelial abnormalities are identified and resected. Moreover, an adequate resection margin may reduce the risk of recurrence.
Subject(s)
Leukoplakia, Oral/pathology , Neoplasm Recurrence, Local/pathology , Age Factors , Aged , Cell Transformation, Neoplastic/pathology , Disease-Free Survival , Epithelium/pathology , Epithelium/surgery , Female , Follow-Up Studies , Forecasting , Gingival Neoplasms/pathology , Gingival Neoplasms/surgery , Humans , Leukoplakia, Oral/surgery , Male , Middle Aged , Precancerous Conditions/pathology , Retrospective Studies , Risk Factors , Tongue Neoplasms/pathology , Tongue Neoplasms/surgery , Treatment OutcomeABSTRACT
For the doctors and other medical staff treating oral cancers, it is necessary to standardize basic concepts and rules on oral cancers to progress in the treatment, research and diagnosis. Oral cancers are integrated in head and neck cancers and are applied to the general rules on head and neck cancer, but it is considered that more detailed rules based on the characteristics of oral cancers are essential. The objectives of this 'General Rules for Clinical and Pathological Studies on Oral Cancer' are to contribute to the development of the diagnosis, treatment and research of oral cancers based on the correct and useful medical information of clinical, surgical, pathological and image findings accumulated from individual patients at various institutions.
Subject(s)
Mouth Neoplasms/diagnosis , Mouth Neoplasms/therapy , Practice Guidelines as Topic/standards , Practice Patterns, Physicians'/standards , Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/therapy , Humans , Pathology, Clinical/methods , Pathology, Clinical/standards , Pathology, Surgical/methods , Pathology, Surgical/standardsABSTRACT
Overexpression of epidermal growth factor receptor (EGFR) is associated with resistance to chemotherapy and radiotherapy, advanced tumor stage, invasion, metastasis and poor prognosis in malignant tumors. EGFR, therefore, has been an attractive molecular target for chemotherapy. However, the results of clinical studies using inhibitors of its kinase activity have not been promising because the response rates were at most 20%. Sodium-glucose co-transporter 1 (SGLT1) is a membrane protein that mediates the transport of glucose across cellular membranes. EGFR physically associates with and stabilizes SGLT1 to promote glucose uptake into cancer cells through a kinase-independent process. The purpose of this study was to investigate the coexpression of SGLT1 and EGFR and its relationships with clinicopathological features in oral squamous cell carcinoma (OSCC). SGLT1 and EGFR were detected in all OSCC cell lines, and the expression levels of SGLT1 were significantly correlated with those of EGFR. Pearson product-moment correlation coefficient of SGLT1 and EGFR was 0.89 (P = 0.016). The immunohistochemical study using the surgical specimens in 52 patients with tongue SCC also showed a significant correlation between SGLT1 and EGFR. Moreover, SGLT1/EGFR expression was inversely related to tumor differentiation among the 5 clinicopathological factors (P = 0.004). SGLT1/EGFR coexpression might be required in the de-differentiation of OSCC, but further study is needed to clarify the implication of these proteins in the manifestation of malignancy and clinical significance.
Subject(s)
Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/pathology , ErbB Receptors/analysis , Mouth Neoplasms/pathology , Sodium-Glucose Transporter 1/analysis , Adult , Aged , Aged, 80 and over , Blotting, Western , Carcinoma, Squamous Cell/secondary , Cell Differentiation/physiology , Cell Line, Tumor , ErbB Receptors/physiology , Female , HeLa Cells , Humans , Immunohistochemistry , Lymphatic Metastasis/pathology , Male , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Staging , Protein Processing, Post-Translational/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sodium-Glucose Transporter 1/physiology , Tongue Neoplasms/pathology , Transfection , Up-Regulation , Young AdultABSTRACT
We investigated the roles of interleukin-6 (IL-6) and parathyroid hormone-related peptide (PTHrP) in oral squamous cell carcinoma (OSCC)-induced osteoclast formation. Microarray analyses performed on 43 human OSCC specimens revealed that many of the specimens overexpressed PTHrP mRNA, but a few overexpressed IL-6 mRNA. Immunohistochemical analysis revealed that IL-6 was expressed not only in cancer cells but also in fibroblasts and osteoclasts at the tumor-bone interface. Many of the IL-6-positive cells coexpressed vimentin. Conditioned medium (CM) derived from the culture of oral cancer cell lines (BHY, Ca9-22, HSC3, and HO1-u-1) stimulated Rankl expression in stromal cells and osteoclast formation. Antibodies against both human PTHrP and mouse IL-6 receptor suppressed Rankl in ST2 cells and osteoclast formation induced by CM from BHY and Ca9-22, although the inhibitory effects of IL6 antibody were greater than those of PTHrP antibody. CM derived from all of the OSCC cell lines effectively induced IL-6 expression in stromal cells, and the induction was partially blocked by anti-PTHrP antibody. Xenografts of HSC3 cells onto the periosteal region of the parietal bone in athymic mice presented histology and expression profiles of RANKL and IL-6 similar to those observed in bone-invasive human OSCC specimens. These results indicate that OSCC provides a suitable microenvironment for osteoclast formation not only by producing IL-6 and PTHrP but also by stimulating stromal cells to synthesize IL-6.
Subject(s)
Carcinoma, Squamous Cell/physiopathology , Cell Differentiation/genetics , Interleukin-6/physiology , Mouth Neoplasms/physiopathology , Osteoclasts/physiology , Parathyroid Hormone-Related Protein/physiology , Stromal Cells/metabolism , Adult , Aged , Aged, 80 and over , Animals , Bone Neoplasms/genetics , Bone Neoplasms/metabolism , Bone Neoplasms/secondary , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Differentiation/drug effects , Cells, Cultured , Female , Gene Expression Regulation, Neoplastic , Humans , Interleukin-6/genetics , Interleukin-6/metabolism , Interleukin-6/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Nude , Middle Aged , Mouth Neoplasms/genetics , Mouth Neoplasms/pathology , Osteoclasts/metabolism , Parathyroid Hormone-Related Protein/genetics , Parathyroid Hormone-Related Protein/metabolism , Parathyroid Hormone-Related Protein/pharmacology , Stromal Cells/drug effects , Stromal Cells/pathology , Transplantation, HeterologousABSTRACT
AIMS: This study aimed to identify relevant keratin subtypes that may associate with the pathogenesis of oral epithelial neoplasms. METHODS AND RESULTS: Expression of all the keratin subtypes was examined by cDNA microarray analysis of 43 oral squamous cell carcinoma (OSCC) cases. Immunohistochemical expression of the major keratins was examined in 100 OSCC and oral epithelial dysplasia (OED) cases. Many changes in keratin expression were observed and, significantly, consistent down-regulation of keratin 4 (K4) and K13 expression was observed. Aberrant expression of K4 and K13 was associated with morphological changes in the affected oral epithelium. Experiments with cell cultures transfected with various keratin subtypes suggested that alterations in keratin subtype expression can cause changes in cell shape and movement. CONCLUSIONS: Aberrant expression of K4 and K13, which are the dominant pair of differentiation-related keratins in oral keratinocytes, indicates dysregulation of epithelial differentiation in OSCC and OED. These keratins, especially K4, may be useful for pathological diagnosis. We propose that the aberrant expression of K4 and K13 and concomitant up-regulation of the other keratins may be one of the causative factors for morphological alterations in the affected epithelium.
Subject(s)
Carcinoma, Squamous Cell/pathology , Keratin-13/genetics , Keratin-4/genetics , Mouth Mucosa/pathology , Mouth Neoplasms/pathology , Biopsy , Carcinoma, Squamous Cell/genetics , Cell Line , Cloning, Molecular , Down-Regulation/genetics , Epithelial Cells/metabolism , Epithelial Cells/pathology , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Keratin-13/metabolism , Keratin-4/metabolism , Male , Mouth Neoplasms/genetics , Oligonucleotide Array Sequence AnalysisABSTRACT
BACKGROUND: The Fas-associated death domain-containing protein, FADD, is an adaptor for relaying apoptotic signals. However, recent studies have shown that FADD also plays an important role in the growth and regulation of the cell cycle. The purpose of this study was to elucidate the role of FADD in oral squamous cell carcinoma (SCC). METHODS: The DNA amplification of FADD from 30 samples of tongue SCC was analyzed using real-time PCR and the protein expression of FADD from 60 samples of tongue SCC was analyzed using immunohistochemistry. RESULTS: The DNA amplifications of FADD were observed in 13 cases (44.3%) and were significantly correlated with the histopathological differentiation grade of SCCs (P = 0.009). FADD expression levels compared with the matched adjacent epithelium increased significantly (P = 0.000). Additionally, the positive expressions of FADD were significantly correlated with lymph node metastasis of SCCs (P = 0.029) and the 5-year disease-specific survival rates (P = 0.049). A positive association between FADD expression level and the histopathological differentiation grade was found to be limited to T1 SCCs (P = 0.019). DNA amplification was moderately correlated (correlation coefficient = 0.406, P = 0.026) with expression of FADD in 30 samples of tongue SCC. CONCLUSION: In tongue SCCs, the expression of FADD was higher when compared with that of adjacent areas, which might be determined via genomic amplification in 11q13.3. Thus, SCC cells with the expression of FADD are possibly more likely to become metastatic and to worsen survival rates.
Subject(s)
Carcinoma, Squamous Cell/genetics , Fas-Associated Death Domain Protein/genetics , Gene Amplification/genetics , Gene Expression Regulation, Neoplastic/genetics , Tongue Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Apoptosis/genetics , Biomarkers, Tumor/analysis , Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/pathology , Cell Cycle/genetics , Cell Line, Tumor , Chromosomes, Human, Pair 11/genetics , Epithelium/pathology , Female , Humans , Immunohistochemistry , Lymphatic Metastasis/genetics , Lymphatic Metastasis/pathology , Male , Middle Aged , Neoplasm Staging , Polymerase Chain Reaction/methods , Survival Rate , Tongue/pathology , Tongue Neoplasms/pathologyABSTRACT
Clinical proteomics using a large archive of formalin-fixed paraffin-embedded (FFPE) tissue blocks has long been a challenge. Recently, a method for extracting proteins from FFPE tissue in the form of tryptic peptides was developed. Here we report the application of a highly sensitive mass spectrometry (MS)-based quantitative proteome method to a small amount of samples obtained by laser microdissection from FFPE tissues. Cancerous and adjacent normal epithelia were microdissected from FFPE tissue blocks of 10 squamous cell carcinomas of the tongue. Proteins were extracted in the form of tryptic peptides and analyzed by 2-dimensional image-converted analysis of liquid chromatography and mass spectrometry (2DICAL), a label-free quantitative proteomics method developed in our laboratory. From a total of 25 018 peaks we selected 72 mass peaks whose expression differed significantly between cancer and normal tissues (P < 0.001, paired t-test). The expression of transglutaminase 3 (TGM3) was significantly down-regulated in cancer and correlated with loss of histological differentiation. Hypermethylation of TGM3 gene CpG islands was observed in 12 oral squamous cell carcinoma (OSCC) cell lines with reduced TGM3 expression. These results suggest that epigenetic silencing of TGM3 plays certain roles in the process of oral carcinogenesis. The method for quantitative proteomic analysis of FFPE tissue described here offers new opportunities to identify disease-specific biomarkers and therapeutic targets using widely available archival samples with corresponding detailed pathological and clinical records.
Subject(s)
Carcinoma, Squamous Cell/chemistry , Neoplasm Proteins/analysis , Tongue Neoplasms/chemistry , Blotting, Western , Carcinoma, Squamous Cell/pathology , Chromatography, Liquid , DNA Methylation , Epigenesis, Genetic , Female , Formaldehyde/chemistry , Gene Silencing , Humans , Immunoblotting , Immunoenzyme Techniques , Male , Microdissection , Middle Aged , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Paraffin Embedding , Proteome/analysis , Proteomics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Tissue Fixation , Tongue Neoplasms/pathology , Transglutaminases/genetics , Transglutaminases/metabolism , Tumor Cells, CulturedABSTRACT
We previously reported the development of an integrated proteome platform, namely 2-Dimensional Image Converted Analysis of Liquid chromatography and mass spectrometry (2DICAL), for quantitative comparison of large peptide datasets generated by nano-flow liquid chromatography (LC) and mass spectrometry (MS). The key technology of 2DICAL was the precise adjustment of the retention time of LC by dynamic programming. In order to apply 2DICAL to clinical studies that require comparison of a large number of patient samples we further refined the calculation algorithm and increased the accuracy and speed of the peptide peak alignment using a greedy algorithm, which had been used for fast DNA sequence alignment. The peptide peaks of each sample with the same m/z were extracted every 1 m/z and displayed with along the horizontal axis. Here we report a precise comparison of more than 150,000 typtic peptide ion peaks derived from 70 serum samples (40 patients with uterine endometrial cancer and 30 controls). The levels of 49 MS peaks were found to differ significantly between cancer patients and controls (P < 0.01, Welch's t-test and interquartile range [IQR] of >40), and the differential expression and identification of selected three proteins was validated by immunoblotting. 2DICAL was is highly advantageous for large-scale clinical proteomics because of its simple procedure, high throughput, and quantification accuracy.
Subject(s)
Biomarkers, Tumor/analysis , Chromatography, Liquid/methods , Endometrial Neoplasms/metabolism , Mass Spectrometry/methods , Proteomics/methods , Algorithms , Electrophoresis, Polyacrylamide Gel , Female , Humans , ImmunoblottingABSTRACT
BACKGROUND: Oral leukoplakias (LP) are the most frequent types of oral pre-cancerous lesions, but there is no accurate assessment of this malignant transformation or even genetic diagnosis of the oral epithelial dysplasia. We need to identify the new genetic diagnosis system of the epithelial dysplasia. METHODS: Oligonucleotide microarray was used to analyze expression patterns of 29,952 genes in 10 LP patients. We compared the different gene expressions between mild dysplasia cases and severe dysplasia cases. RESULTS: Ninety-six genes expressed differentially were selected as candidates for up-regulated in severe dysplasia. Subsequently, we further selected 16 genes with highest differentially expression. By hierarchical clustering analysis, the 10 cases were divided mild dysplasia from severe dysplasia. CONCLUSIONS: The 16 genes are suggested as biomarker gene sets of efficacy and quickly recognized in the development of oral epithelial dysplasia.
Subject(s)
Cell Transformation, Neoplastic/genetics , Leukoplakia, Oral/genetics , Mouth Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Cluster Analysis , Epithelium/pathology , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Humans , Male , Middle Aged , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction , Up-RegulationABSTRACT
PURPOSE: Ultrasonography is a useful diagnostic modality for the head and neck region. The mode of invasion is one of the predictive factors for the cervical lymph node metastasis. The purpose of this study is to evaluate the correlation between quantified invasive fronts from ultrasonographic images and the pathological malignancy grading of tongue squamous cell carcinoma. MATERIALS AND METHODS: Forty-eight previously untreated T1-2N0 tongue squamous cell carcinoma patients were enrolled. The ultrasonographic images of intraoral lesions and the excised lesions were collected. The invasive front on the ultrasonographic image was analyzed by a multipurpose software package. The length of the invasive front and the line of smoothed invasive front were measured and the invasive front ratio was calculated. The hematoxylin and eosin stained sections were assessed according to modified Jakobsson's malignancy grading as low and high malignancy grade groups. The correlation between invasive front ratio and the histological malignancy grade groups was evaluated. RESULTS: The mean invasive front ratio for the excised lesions was 1.145 in low malignancy grade group and 1.248 in high malignancy grade group. These values as determined for the intraoral lesions were 1.074 in the low malignancy grade group and 1.174 in high malignancy grade group. Significant statistical differences were observed between the 2 groups by Mann-Whitney's U test in both images. CONCLUSIONS: Invasive front ratio is related to the histological malignancy grade group. It can be considered to be a valuable diagnostic method which can predict neck node metastasis, and help surgeons to choose adequate neck treatment.
Subject(s)
Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/pathology , Neoplasm Staging/methods , Tongue Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/diagnostic imaging , Female , Head and Neck Neoplasms/ultrastructure , Humans , Image Processing, Computer-Assisted , Lymphatic Metastasis/diagnostic imaging , Male , Middle Aged , Neoplasm Invasiveness/diagnostic imaging , Neoplasm Invasiveness/pathology , Predictive Value of Tests , Sensitivity and Specificity , Severity of Illness Index , Statistics, Nonparametric , Tongue Neoplasms/diagnostic imaging , Ultrasonography/instrumentation , Ultrasonography/methods , Young AdultABSTRACT
This study examines the psychological states and QOL in oral cancer patients during the perioperative and postoperative survival periods. Those patients who were scheduled for and had undergone primary surgery at the Oral and Maxillofacial Surgery Section, Tokyo Medical and Dental University Hospital, Tokyo, Japan were selected for this study. They took two different kinds of tests, i. e. the Hospital Anxiety and Depression Scale (HADS) and the Japanese-language version of the Functional Assessment of Cancer Therapy Head and Neck (FACT-H & N) version 4. In a longitudinal study, interval assessments were done at one day before surgery, one week after surgery and one month and six months each after being discharged from the hospital, respectively. In a cross-sectional study, outpatients during the postoperative follow-up periods were evaluated. Statistically, before surgery psychological anxiety became highest, while after surgery depression grew and QOL in the somatic and specific domains decreased. After discharge from the hospital, the patients with longer-term postoperative survival had better psychological states and QOL. These results provide important information regarding psychological states and QOL in oral cancer patients for caring and supporting based on perioperative and postoperative periods.
Subject(s)
Mouth Neoplasms/psychology , Mouth Neoplasms/surgery , Aged , Cross-Sectional Studies , Female , Humans , Longitudinal Studies , Male , Middle Aged , Psychological Tests , Quality of LifeABSTRACT
PURPOSE: Atrophy of the alveolar ridge is a problem in prosthetic and esthetic treatment. In the present study, to examine effects of PGE1 on the alveolar bone after tooth extraction, PGE1 was applied to rat incisal sockets utilizing a slow drug release system using PLGA as the drug carrier. MATERIALS AND METHODS: Thirty-six male Wistar rats, 10 weeks old, were divided into 3 groups. After all right mandibular incisors were extracted, the sockets were treated in the following manner. The first group was untreated (control group), the second group received a PLGA rod (PLGA group), and the third group was treated with a PLGA rod containing 0.5 mg PGE1 (PGE1 group). Six rats in each group were sacrificed at 4 weeks, and the remaining rats were sacrificed at 8 weeks. For fluorescence labeling, half of the animals were injected with calcein and tetracycline 8 days and 1 day before sacrifice, respectively. After sacrifice, the mandibles were radiologically and histologically examined. RESULTS: In the PGE1 group, the bone volume of the alveolar ridge including the socket was significantly (P < .05) greater than in the control and PLGA groups at 4 and 8 weeks. At 4 weeks in the PGE1 group, the mineral apposition rate and number of osteoclasts were higher than in the other groups, whereas these parameters were similar in all groups at 8 weeks. CONCLUSION: Based on this animal study, it appears that local application has the potential to preserve and/or augment the alveolar ridge after tooth extraction.